- Integration
- The FDA summary describes DICOM-compliant image viewing and data management across multiple modalities; validate identifiers, display calibration, presentation states, annotations, routing, archive, and downtime locally.
FDA source Exact FDA submission Checked 2026-09-04
The exact FDA material describes this input or interface boundary; local interoperability acceptance remains necessary.
- Deployment and data flow
- The FDA summary describes a web-based viewer that is part of a server and uses off-the-shelf computing devices; exact hosting, availability, security, browser support, and responsibility remain unverified.
FDA source Exact FDA submission Checked 2026-09-04
The exact FDA material describes this release-level deployment boundary; hosting, contracts, security, availability, and site configuration remain separate evidence.
- Security and privacy
- Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04
Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
- Training and support
- Only radiologists, physicians, technologists, surgeons, and other trained clinical image users should operate or interpret this product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
FDA source Exact FDA submission Checked 2026-09-04
- Monitoring and change control
- Monitor by exact hardware, software, model, algorithm, reconstruction, or configuration version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: The FDA material states that display monitors, lighting, image quality, compression, and calibration must be appropriate for the clinical purpose and that lossy compression is not for primary mammography reading. It does not establish a universal diagnostic-performance claim.
FDA source Exact FDA submission Checked 2026-09-04
Release and scope verification
Map installed model, build, options, population, anatomy, inputs, outputs, and enabled functions to K242362 before acceptance. Later family features are not evidence for this exact submission.
exact submission · checked 2026-09-04 Interoperability acceptance
The FDA summary describes DICOM-compliant image viewing and data management across multiple modalities; validate identifiers, display calibration, presentation states, annotations, routing, archive, and downtime locally. Test representative identifiers, geometry, measurements, units, routing, failure handling, and round trips locally.
exact submission · checked 2026-09-04 Deployment and security qualification
The FDA summary describes a web-based viewer that is part of a server and uses off-the-shelf computing devices; exact hosting, availability, security, browser support, and responsibility remain unverified. Security, availability, retention, and service responsibilities remain unverified.
exact submission · checked 2026-09-04 Clinical acceptance
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. The FDA material states that display monitors, lighting, image quality, compression, and calibration must be appropriate for the clinical purpose and that lossy compression is not for primary mammography reading. It does not establish a universal diagnostic-performance claim.
exact submission · checked 2026-09-04 Define stop-use, escalation, rollback, and revalidation triggers before production use.
Economic evaluation
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs. No exact-product price was found.
product family · checked 2026-09-04 Lifecycle monitoring
Monitor by exact hardware, software, model, algorithm, reconstruction, or configuration version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: The FDA material states that display monitors, lighting, image quality, compression, and calibration must be appropriate for the clinical purpose and that lossy compression is not for primary mammography reading. It does not establish a universal diagnostic-performance claim.
exact submission · checked 2026-09-04 Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.